Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women

Circulation

Volumn 89, Issue 6, 1994, Pages 2545-2551

  Gilligan, David M ^a   Quyyumi, Arshed A ^a   Cannon III, Richard O ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

coronary artery disease; endothelium; estrogen; menopause; nitric oxide

Indexed keywords

ACETYLCHOLINE; ADENOSINE; ALCOHOL; ESTRADIOL; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ADULT; AGED; ARTERY DIAMETER; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTERY RESISTANCE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; DOSE RESPONSE; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRACORONARY INFUSION; POSTMENOPAUSE; PRIORITY JOURNAL; VASOMOTOR REFLEX;

EID: 0028358749     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.89.6.2545     Document Type: Article

References (34)

1. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease. JAMA. 1991;265:1861-1867.
2. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991;20:47-63.
3. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N Engl J Med. 1991;325:756-762.
4. Bush TL, Miller VT. Effects of pharmacologic agents used during menopause: impact on lipids and lipoproteins. In: Mishell D, ed. Menopause: Physiology and Pharmacology. Chicago, I11: Year Book Medical; 1986:187-208.
5. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentration and metabolism of plasma lipoproteins. N Engl J Med. 1991;325:1196-1204.
6. Gisclard V, Miller VM, Vanhoutte PM. Effect of 17 β-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther. 1988;244:19-22.
7. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 1990; 81:1680-1687.
8. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol. 1992;20: 452-457.
9. Miller VM, Vanhoutte PM. 17β-Estradiol augments endothelium-dependent contractions to arachidonic acid in rabbit aorta. Am J Physiol. 1990;258:R1502-R1507.
10. Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. Br J Pharmacol. 1991;104:1033-1037.
11. Reis SE, Gloth ST, Blumenthal RS, Resar JR, Zacur HA, Gerstenblith G, Brinker JA. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation. 1994;89:52-60.
12. Doucette JW, Corl PD, Payne HM, Flynn AE, Goto M, Itasi M, Segal J. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation. 1992;85: 1899-1911.
13. Abraham GE, Odell WD, Swerdloff RS, Hopper K. Simultaneous radioimmunoassay of plasma FSH, LH, progesterone, 17-hydroxyprogesterone, and estradiol-17β during the menstrual cycle. J Clin Endocrinol Metab. 1972;34:312-318.
14. Herrington DM, Braden GA, Downes TR, Williams JK. Estrogen modulates coronary vasomotor responses in postmenopausal women with early atherosclerosis. Circulation. 1992;86(suppl I): I-619. Abstract.
15. Lieberman EH, Gerhard M, Yeung AC, Anderson TJ, Meredith IT, Ganz P, Selwyn AP. Estrogen improves coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation. 1993;88(suppl I):I-79. Abstract.
16. Collins P, Rosano GMC, Adamopoulos S, McNeil J, Virich L, Sarrel PM, Poole-Wilson PA. Reversal of acetylcholine-induced vasoconstriction by intracoronary administration of estradiol-17β in menopausal women with coronary artery disease. Circulation. 1993;88(suppl I):I-589. Abstract.
17. Rosano GMC, Sarrel PM, Poole-Wilson PA, Collins P. Beneficial effect of oestrogen on exercise-induced myoeardial ischaemia in women with coronary artery disease. Lancet. 1993;342: 133-136.
18. Bell C. Oestrogen-induced sensitization of the uterine artery of the guinea pig to acetylcholine. Br J Pharmacol. 1973;49:595-601.
19. Bell C, Coffey C. Factors influencing oestrogen-induced sensitization to acetylcholine of guinea-pig uterine artery. J Reprod Fertid. 1982;66:133-137.
20. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO. The acute vascular effects of 17β-estradiol in postmenopausal women. J Am Coll Cardiol. 1993;21:423A. Abstract.
21. Vanhoutte PM, Shimokawa H. Endothelium-derived relaxing factor and coronary vasospasm. Circulation. 1989;80:1-9.
22. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med. 1990;323:27-36.
23. Sack MN, Rader DJ, Cannon RO. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet. 1994;343:269-270.
24. Flavahan NA. Atherosclerosis or lipoprotein-induced endothelial dysfunction: potential mechanisms underlying reduction in EDRF/ nitric oxide activity. Circulation. 1992;85:1927-1938.
25. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Gantz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986;315:1046-1051.
26. Zeiher AM, Drexler H, Wollschläger H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83:391-401.
27. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
28. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 1993;87:1468-1474.
29. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 1992;90: 1248-1253.
30. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg GM, Panza JA. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation. 1993;88:2541-2547.
31. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest. 1992;90: 2548-2554.
32. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, Andrews JW. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992;35: 771-776.
33. Ware JA, Heistad DD. Platelet-endothelium interactions. N Engl J Med. 1993;328:628-635.
34. Dzau VJ, Gibbons GH, Cooke JP, Omoigui N. Vascular biology and medicine in the 1990s: scope, concepts, potentials, and perspectives. Circulation. 1993;87:705-719.